Innovassynth [INOVSYNTH] vs Neogen Chemicals [NEOGEN] Detailed Stock Comparison

Innovassynth Investments Ltd.

BSE
Loading...

Neogen Chemicals Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Innovassynth Investments Ltd. wins in 7 metrics, Neogen Chemicals Ltd. wins in 11 metrics, with 0 ties. Neogen Chemicals Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Innovassynth Investments Ltd. Neogen Chemicals Ltd. Better
P/E Ratio (TTM) 140.85 222.22 Innovassynth Investments Ltd.
Price-to-Book Ratio 7.73 5.46 Neogen Chemicals Ltd.
Debt-to-Equity Ratio 16.05 141.47 Innovassynth Investments Ltd.
PEG Ratio -0.74 -3.52 Innovassynth Investments Ltd.
EV/EBITDA -154.19 42.55 Neogen Chemicals Ltd.
Profit Margin (TTM) 0.00% 2.41% Neogen Chemicals Ltd.
Operating Margin (TTM) -26.90% 11.39% Neogen Chemicals Ltd.
EBITDA Margin (TTM) N/A 11.39% N/A
Return on Equity -11.10% 4.41% Neogen Chemicals Ltd.
Return on Assets (TTM) -9.65% 1.99% Neogen Chemicals Ltd.
Free Cash Flow (TTM) $-7.26M $-1.22B Innovassynth Investments Ltd.
Dividend Yield N/A 0.19% N/A
1-Year Return 13.39% 10.59% Innovassynth Investments Ltd.
Price-to-Sales Ratio (TTM) 698.30 5.56 Neogen Chemicals Ltd.
Enterprise Value $6.09B $53.55B Neogen Chemicals Ltd.
EV/Revenue Ratio 672.12 6.55 Neogen Chemicals Ltd.
Gross Profit Margin (TTM) 83.89% 47.11% Innovassynth Investments Ltd.
Revenue per Share (TTM) $0 $310 Neogen Chemicals Ltd.
Earnings per Share (Diluted) $-9.19 $7.47 Neogen Chemicals Ltd.
Beta (Stock Volatility) -0.16 0.22 Innovassynth Investments Ltd.

Innovassynth Investments Ltd. vs Neogen Chemicals Ltd. Stock Performance Analysis

Loading Price Chart...

INOVSYNTH
NEOGEN

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Innovassynth Investments Ltd.4.99%14.48%41.00%29.79%17.56%8.70%
Neogen Chemicals Ltd.1.29%6.97%12.71%39.41%74.21%61.67%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Innovassynth Investments Ltd.13.39%232.10%806.64%1,161.78%935.82%637.12%
Neogen Chemicals Ltd.10.59%19.04%106.75%609.06%609.06%609.06%

Performance & Financial Health Analysis: Innovassynth Investments Ltd. vs Neogen Chemicals Ltd.

MetricINOVSYNTHNEOGEN
Market Information
Market Cap i₹6.04B₹44.76B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i25,534170,744
90 Day Avg. Volume i27,182127,390
Last Close₹91.72₹1,901.20
52 Week Range₹50.10 - ₹139.85₹966.70 - ₹1,960.30
% from 52W High-34.42%-3.01%
All-Time High₹139.85 (Aug 06, 2025)₹2,420.00 (Dec 09, 2024)
% from All-Time High-34.42%-21.44%
Growth Metrics
Quarterly Revenue GrowthN/A0.09%
Quarterly Earnings GrowthN/A-0.63%
Financial Health
Profit Margin (TTM) i0.00%0.02%
Operating Margin (TTM) i-0.27%0.11%
Return on Equity (TTM) i-0.11%0.04%
Debt to Equity (MRQ) i16.05141.47
Cash & Liquidity
Book Value per Share (MRQ)₹10.85₹303.78
Cash per Share (MRQ)₹0.01₹57.58
Operating Cash Flow (TTM) i₹-42,662,000₹645.50M
Levered Free Cash Flow (TTM) i₹-46,874,000₹348.30M
Dividends
Last 12-Month Dividend Yield iN/A0.19%
Last 12-Month Dividend iN/A₹3.00

Valuation & Enterprise Metrics Analysis: Innovassynth Investments Ltd. vs Neogen Chemicals Ltd.

MetricINOVSYNTH (Apr 24, 2026)NEOGEN (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i140.85222.22
Forward P/E iN/A72.26
PEG Ratio i-0.74-3.52
Price to Sales (TTM) i698.305.56
Price to Book (MRQ) i7.735.46
Market Capitalization
Market Capitalization i₹6.04B₹44.76B
Enterprise Value i₹6.09B₹53.55B
Enterprise Value Metrics
Enterprise to Revenue i672.126.55
Enterprise to EBITDA i-154.1942.55
Risk & Other Metrics
Beta i-0.160.22
Book Value per Share (MRQ) i₹10.85₹303.78

Financial Statements Comparison: Innovassynth Investments Ltd. vs Neogen Chemicals Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricINOVSYNTH (2025)NEOGEN (2025)
Revenue/Sales i07.58B
Cost of Goods Sold i04.44B
COGS % of Revenue i-58.6%
Gross Profit i03.13B
Gross Margin i-41.4%
Research & Development iN/A11.50M
Operating Income (EBIT) i-4.17M1.09B
Operating Margin i-14.4%
EBITDA i-39.51M1.31B
EBITDA Margin i-17.3%
Pre-Tax Income i-46.87M501.60M
Pre-Tax Income % of Revenue i-6.6%
Income Tax i0153.30M
Income Tax % of Revenue i-2.0%
Net Income (Profit) i-46.87M348.30M
Profit Margin i-4.6%

Balance Sheet & Liquidity Metrics

MetricINOVSYNTH (2025)NEOGEN (2025)
Cash & Equivalents i530,00049.60M
Total Current Assets i687,00010.00B
Total Current Assets % of Revenue i-132.0%
Total Current Liabilities i63.55M7.33B
Total Current Liabilities % of Revenue i-96.8%
Long-Term Debt iN/A1.94B
Long-Term Debt % of Revenue i-25.6%
Total Shareholders Equity i422.42M7.89B
Retained Earnings i-94.79M2.28B
Retained Earnings % of Revenue i-30.1%
Property, Plant & Equipment iN/A890.30M

Cash Flow Statement Comparison

MetricINOVSYNTH (2025)NEOGEN (2025)
Operating Cash Flow i-42.66M645.50M
Operating Cash Flow % of Revenue i-8.5%
Capital Expenditures iN/A-3.17B
Free Cash Flow i-7.26M-1.22B
FCF Margin i--16.1%
Debt Repayment iN/A-718.00M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricINOVSYNTHNEOGEN
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i75.45M27.38M
Float Shares i16.82M13.28M
% Held by Insiders i78.91%53.98%
% Held by Institutions i1.03%23.81%
% Held by Public i20.06%22.21%

Dividend Analysis & Yield Comparison: Innovassynth Investments Ltd. vs Neogen Chemicals Ltd.

MetricINOVSYNTHNEOGEN
Last 12-Month Dividend iN/A₹3.00
Last 12-Month Dividend Yield iN/A0.19%
3-Year Avg Annual Dividend iN/A₹2.00
3-Year Avg Dividend Yield iN/A0.11%
3-Year Total Dividends iN/A₹6.00
Ex-Dividend DateN/ASep 19, 2025